These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 24353333)

  • 1. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.
    Roberts RO; Knopman DS; Mielke MM; Cha RH; Pankratz VS; Christianson TJ; Geda YE; Boeve BF; Ivnik RJ; Tangalos EG; Rocca WA; Petersen RC
    Neurology; 2014 Jan; 82(4):317-25. PubMed ID: 24353333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.
    Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D;
    J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MCI subtype and reversion on progression to dementia in a community sample.
    Aerts L; Heffernan M; Kochan NA; Crawford JD; Draper B; Trollor JN; Sachdev PS; Brodaty H
    Neurology; 2017 Jun; 88(23):2225-2232. PubMed ID: 28490651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
    Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.
    Brodaty H; Heffernan M; Kochan NA; Draper B; Trollor JN; Reppermund S; Slavin MJ; Sachdev PS
    Alzheimers Dement; 2013 May; 9(3):310-317.e1. PubMed ID: 23110866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.
    Alhurani RE; Vassilaki M; Aakre JA; Mielke MM; Kremers WK; Machulda MM; Geda YE; Knopman DS; Petersen RC; Roberts RO
    JAMA Neurol; 2016 Apr; 73(4):439-46. PubMed ID: 26831542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Mild Cognitive Impairment, Dementia and Mortality: The Sydney Memory and Ageing Study.
    Lipnicki DM; Crawford J; Kochan NA; Trollor JN; Draper B; Reppermund S; Maston K; Mather KA; Brodaty H; Sachdev PS;
    J Am Med Dir Assoc; 2017 May; 18(5):388-395. PubMed ID: 28043804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment.
    Koch M; Fitzpatrick AL; Rapp SR; Nahin RL; Williamson JD; Lopez OL; DeKosky ST; Kuller LH; Mackey RH; Mukamal KJ; Jensen MK; Sink KM
    JAMA Netw Open; 2019 Sep; 2(9):e1910319. PubMed ID: 31560382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
    Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
    JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing Loss and Risk of Mild Cognitive Impairment and Dementia: Findings from the Singapore Longitudinal Ageing Study.
    Heywood R; Gao Q; Nyunt MSZ; Feng L; Chong MS; Lim WS; Yap P; Lee TS; Yap KB; Wee SL; Ng TP
    Dement Geriatr Cogn Disord; 2017; 43(5-6):259-268. PubMed ID: 28420004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.
    Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L
    J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.
    Pankratz VS; Roberts RO; Mielke MM; Knopman DS; Jack CR; Geda YE; Rocca WA; Petersen RC
    Neurology; 2015 Apr; 84(14):1433-42. PubMed ID: 25788555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of mild cognitive impairment by definition: a population study.
    Ganguli M; Snitz BE; Saxton JA; Chang CC; Lee CW; Vander Bilt J; Hughes TF; Loewenstein DA; Unverzagt FW; Petersen RC
    Arch Neurol; 2011 Jun; 68(6):761-7. PubMed ID: 21670400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.
    Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T
    J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.